Skip to content

Subsequent malignant neoplasm among cancer survivors in the United States.

Aug 2026 · Journal of cancer survivorship · 0 citations · 24 references
Medicine

TL;DR

More than 2.5 million cancer survivors in the US have had two or more malignancies, representing 15% of the US cancer survivor population, and the risk of SMN is notable for those diagnosed at a younger age and with certain types of first malignancies.

View source

Similar papers

Open access Sep 2026

Prevalence of cancer survivors diagnosed within the past 20 years accounts for 6%: a population-based study in Hiroshima, Japan.

For cancer survivorship care planning, we measured population-based 20-year prevalence in Hiroshima, Japan. Twenty-year limited-duration prevalence was calculated as the number of individuals aged 0-99 years alive on 31 December 2021 who had been diagnosed with cancer during 2002-2021. A total of 166 854 survivors of i...

Hiromi Sugiyama, M. Hori, M. Utada et al. · 0 citations
Open access Sep 2026

The impact of prevalent primary cancers in melanoma patients on survival

Background The presence of prior malignancies at the time of cutaneous malignant melanoma diagnosis may be a critical determinant of patient survival. The present study evaluated the clinical and economic impact of prevalent cancers at the time of cutaneous melanoma diagnosis. Methods This population-based retrospectiv...

Alessandra Buja, S. Guzzinati, Chiara Trevisiol et al. · 0 citations
Open access Oct 2026

Risk factors for subsequent thyroid neoplasms development in childhood cancer survivors.

Subsequent thyroid carcinomas (STC) are common after childhood cancer treatment and have well-described risk factors, whereas information on subsequent thyroid adenomas (STA) remains limited. This study compared treatment-related risk factors for STC and STA, assessed their associations with the other subsequent neopla...

D. Nováková, K. Svojgr, Rami Katra et al. · 0 citations
Review Open access Sep 2026

Cancer incidence and mortality worldwide (review)

Background. Cancer remains one of the leading causes of mortality worldwide. this review analyzes global cancer incidence and mortality rates for 2022 and their association with the Human Development Index (HDI). Material and Methods. The methodology involved a search of the PubMed and eLibrary.ru databases using...

L. D. Zhuikova, E. L. Choynzonov, O. Ananina et al. · 0 citations
Review Aug 2026

Cancer Prevalence and Associated Health Outcomes Among Adults With HIV in the United States: Medical Monitoring Project Data, 2019-2022 Cycle Years.

ABSTRACT We present nationally representative estimates of cancer diagnoses among US persons with HIV (PWH) using data from the Medical Monitoring Project, a complex sample survey of US adults with diagnosed HIV. Data were collected June 2019-May 2023 from a probability sample of 14,798 PWH. Weighted frequencies and pe...

Eve E. Koehler, Y. Tie, Yishiow Kuo et al. · 0 citations
Sep 2026

Cancer rarity and mortality: Evidence from a nationwide cohort study.

BACKGROUND Patients with rare cancers have consistently been reported to have poorer survival than patients with common cancers. We hypothesized that the excess mortality could be attributable to differences in tumor histology and stage at diagnosis and, explored whether it reflected a broader relationship between canc...

S. M. Kønig, S. Friis, T. Kjær et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.